WEE1 and acute lymphoblastic leukemia: Irrespective of this, our work greatly corroborates findings that WEE1 kinase activity is critical for maintaining genomic integrity in proliferating ALL blasts and substantiate WEE1 inhibition as a viable p53-independent therapeutic strategy for high-risk and relapsed ALL that should be considered for future clinical evaluation.